NCT03124043View on ClinicalTrials.gov

Get In Touch Phase 2

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

May 1, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

Livongo for Diabetes program

See description in arm/group description.

Sponsors

Collaborators (1)

Livongo Health
All Listed Sponsors
collaborator

Livongo Health

INDUSTRY

lead

University of Massachusetts, Worcester

OTHER

NCT03124043 - Get In Touch Phase 2 | Biotech Hunter | Biotech Hunter